Reporting Owner Activity for Eric Thomas Schmidt

Form 3/4/5 issuer positions and transaction evidence for this reporting owner.

Issuer positions

3

Largest position

Allogene Therapeutics, Inc.

Disclosed value

$6.97M

Recent activity

Available

Identity 1 fact
Location
South San Francisco, CA
SEC ownership signals 1 fact
Owner position summary

Reported owner value

$6,970,301

Estimated from parsed Forms 3/4/5 when the filing discloses holding values.

Issuer count

3

Distinct issuers tied to this reporting owner in parsed SEC filings.

Largest reported position

Allogene Therapeutics, Inc. (ALLO)

About $6.4M reported in parsed owner filings.

Latest owner filing

12 Jun 2023

Most recent owner-level filing date in the parsed SEC record.

+1 more

Additional issuer positions are listed below.

Reported values are estimates from parsed SEC Forms 3/4/5. Verify the source filing before making decisions.

SEC filing record 1 fact
SEC signature
/s/ Jack Anders, as Attorney-in-fact for Eric Schmidt
SEC evidence 1 fact
Source evidence
Open source filing history

Follow Filing Activity

Follow Eric Thomas Schmidt and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Reported issuer positions for Eric Thomas Schmidt

Insider Transactions Reported by Eric Thomas Schmidt:

Sym Company Class Transaction % Reported value Reported price Shares Shares after Date Ownership
* indicates a reported price that failed the local validity check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .